BEACON - A phase IV assessor-blind randomised control trial comparing the effectiveness, tolerability and cost effectiveness of ciclosporin, methotrexate, and dupilumab in adults with moderate-severe eczema

Project Details

StatusActive
Effective start/end date14/11/24 → 30/11/27

Funding

  • Pfizer: £54,689.93